Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.12.015

IF 25.3 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2025-04-16 DOI:10.1016/j.eururo.2025.02.031

Felix Melchior, Andreas Pircher, Isabel Heidegger

引用次数: 0

Abstract

No Abstract

查看原文本刊更多论文

Re: Johann S. de Bono，孟He，陈实，等。在IPATential150期临床试验中，接受Ipatasertib和Abiraterone的患者的最终总生存期和与临床结果相关的分子数据。Urol欧元。在出版社。https://doi.org/10.1016/j.eururo.2024.12.015

没有抽象的

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.